Back to Journals » Clinical Ophthalmology » Volume 6

Opaque intraocular lens implantation: a case series and lessons learnt

Authors Lee R, Dubois, Mavrikakis I, Okera, Ainsworth, Vickers, Liu C

Received 5 November 2011

Accepted for publication 24 November 2011

Published 5 April 2012 Volume 2012:6 Pages 545—549

DOI https://doi.org/10.2147/OPTH.S27972

Review by Single-blind

Peer reviewer comments 3


Richard MH Lee1, Vincent DJP Dubois1, Ioannis Mavrikakis1, Salim Okera1, Gerard Ainsworth1, Sarah Vickers1, Christopher SC Liu1,2

1Department of Ophthalmology, Sussex Eye Hospital, Brighton, UK; 2Tongdean Eye Clinic, Hove, UK

Purpose: To report the use of opaque intraocular devices in three patients with complex neuro-ophthalmic symptoms.
Methods: A case series of three patients with neuro-ophthalmic symptoms requiring occlusion of one eye when alternative methods had failed to control symptoms. Morcher (Stuttgart, Germany) opaque intraocular implants were used in all patients.
Results: All three patients observed an improvement in symptoms following opaque intraocular device implantation. One patient (Case 2) required multiple devices for symptom relief.
Conclusion: Opaque intraocular occlusive devices are an increasingly popular choice for clinicians in patients with intractable diplopia but we highlight their use in patients with other complex neuro-ophthalmic symptoms. We learned a number of useful lessons in these patients as summarized in this case series.

Keywords: intraocular lens, opaque IOL, occlusive IOL, occlusive intraocular lens, diplopia implant

A Letter to the Editor has been received and published for this article.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]